US FDA Struggling To Regulate Supplement Industry – Former Agency Chief Counsel

Market Growth, Plus Cannabinoids And NDI Notifications, Put Agency In Bind

Stacy Cline Amin expects publication in “near future” of draft guidance on FDA’s NDI notification requirement, a document the agency says it expects to provide within a year. Amin, now with Morrison & Foerster as partner in Washington, also acknowledged FDA’s predicament with regulating products containing cannabinoids.

A former chief counsel for the US Food and Drug Administration says cannabinoids have put it in a “nearly impossible situation” while the agency’s overall regulatory oversight of the dietary supplement industry lags behind the growth of the market.

Stacy Cline Amin, commenting via email on questions from HBW Insight, also said she expects publication in the “near future”...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation